MediWales Connects NHS Collaboration Conference 2023

Our Group CEO John McKinley ,Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will be in attendance hosting our exhibiting stand with our BreathSpec® V2 device. We look forward to seeing you there! Discover more at:

BioWales in London

Our Group CEO John McKinley will be presenting in the Company Showcase and participating in the Finance and Funding Panel at BioWales London on Tuesday 14th March 2023. Our Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will also be in attendance hosting our exhibiting stand with our BreathSpec® device. We look forward to seeing […]

Arab Health 2023

Our Group CEO, John McKinley will be joining the Welsh Government and ABHI UK Pavilion at Arab Health 2023 in Dubai, UAE from Monday 30th January – Thursday 2nd February on behalf of Imspex seeking growth capital, leading development and commercialisation partners. He will be situated in Hall2 Stand D30. John will also be presenting […]

Imspex is looking for a consortium

IMSPEX is looking for a consortium in the ihi call 3: Screening platform and biomarkers for prediction and prevention of diseases of unmet public health need. IMSPEX are pioneers in Gas Chromatography Ion Mobility Spectrometry (GC-IMS) technology, delivering fast, accurate, lab-quality analysis on-line, at-site, in the laboratory and at point-of-care. Improving outcomes for people remains […]

Group B Streptococcus

Group B streptococcus (GBS) is a common bacterium found in the vagina of about 2 in 10 women in the UK. Being a carrier is not harmful to you, however, many babies come into contact with GBS during labour. The vast majority of babies will suffer no ill effects. However, if GBS is passed from […]

Urine analysis for disease diagnostics or rapid screening

IMSPEX are working closely with partners to develop rapid screening tests using urine analysis. Direct headspace of urine allows rapid analysis of the volatile organic compounds (VOCs) in the sample, which has the potential to diagnose or triage a patient with suspected disease. See the work carried out so far here: Prostate and Bladder Cancers: […]

TOXI- Triage

In October 2018, Imspex/GAS were in Athens, involved in a full-scale field trial of ground breaking new technologies designed to improve the way the emergency services triage casualties following a chemical, biological, radioactive or nuclear (CBRN) incident taking place. Discover more about how the Breathspec® was used in this scenario… Field Exercise Video The […]

TOXI – Triage – DISPERSE exercise

On 22nd May in Mikkeli, Finland, Imspex/GAS took part in the second TOXI- triage field exercise, DISPERSE. DISPERSE scenario simulated a chemical incident in a town centre. In this large-scale simulated CBRN incident TOXI‐triage’s technology and operational proposals have been evaluated. Handheld and drone mounted chemical and radiological detectors, breath analysis technologies, tag and trace […]

Leicester publication highlights Imspex and GC-IMS

Discriminatory Ability of Gas Chromatography–Ion Mobility Spectrometry to Identify Patients Hospitalized With COVID-19 and Predict Prognosis….. ‘GC-IMS shows promise as both a diagnostic tool and a predictor of prognosis in hospitalised patients with COVID-19 and should be assessed further in larger studies.’ The publication presents the use of the Breathspec for COVID diagnostics and as […]

MediWales Innovation Awards 2022

Our Imspex team look forward to attending this year’s MediWales Innovation Awards at the Mercure Cardiff Holland House on Thursday 8th December. Further information about this event can be found on their website


Imspex are proud to be a part of the EU-funded ONELAB project. ONELAB focuses on designing and coordinating mobile laboratory operations for the detection and identification of infectious agents enabling enhanced situational awareness through integrated data communication that supports multi-agency decision-making and leadership See how the Breathspec® will be used in this project in both […]


PRESS RELEASE 9th August, 2022 Imspex Diagnostics announces BreathSpec® Instrument Receives CE Mark for Covid-19 testing Abercynon, Wales, UK – Imspex Diagnostics Ltd today announced that it has received CE mark for its BreathSpec® instrument for the detection of COVID-19 using non-invasive breath testing and analysis having met the requirements of the European In-Vitro Diagnostics […]